Arteris, Inc. (NASDAQ:AIP - Get Free Report) COO Laurent R. Moll sold 34,400 shares of Arteris stock in a transaction that occurred on Tuesday, August 5th. The stock was sold at an average price of $13.57, for a total transaction of $466,808.00. Following the completion of the transaction, the chief operating officer directly owned 442,071 shares in the company, valued at approximately $5,998,903.47. The trade was a 7.22% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Arteris Price Performance
AIP traded up $0.02 during trading on Monday, hitting $9.32. The stock had a trading volume of 159,347 shares, compared to its average volume of 538,752. Arteris, Inc. has a one year low of $5.46 and a one year high of $14.29. The firm has a market cap of $397.28 million, a price-to-earnings ratio of -11.37 and a beta of 1.45. The company has a 50 day moving average price of $9.15 and a 200-day moving average price of $8.32.
Institutional Investors Weigh In On Arteris
Several large investors have recently added to or reduced their stakes in AIP. Cambridge Investment Research Advisors Inc. bought a new position in shares of Arteris in the first quarter valued at approximately $95,000. G2 Investment Partners Management LLC bought a new stake in Arteris during the fourth quarter worth about $2,799,000. BNP Paribas Financial Markets bought a new stake in shares of Arteris in the 4th quarter valued at about $214,000. Two Sigma Advisers LP grew its holdings in shares of Arteris by 82.9% during the 4th quarter. Two Sigma Advisers LP now owns 23,600 shares of the company's stock worth $240,000 after acquiring an additional 10,700 shares during the period. Finally, EAM Investors LLC purchased a new stake in shares of Arteris in the 4th quarter worth approximately $983,000. Institutional investors and hedge funds own 64.36% of the company's stock.
Analysts Set New Price Targets
A number of brokerages have weighed in on AIP. TD Cowen lifted their price target on shares of Arteris from $12.00 to $15.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. Rosenblatt Securities restated a "buy" rating and set a $14.00 price objective on shares of Arteris in a report on Wednesday, May 21st.
Read Our Latest Stock Report on Arteris
About Arteris
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
See Also

Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.